Some of our research projects rely on the generosity of people like you. Whether it's harnessing the power of your home PC, taking part in a clinical trial, or simply volunteering your time for a study, you may be able to contribute to some of the ground-breaking projects which make the University of Oxford a world leader in research. Watch this space for ways in which you could get involved.
We are looking for you!
Who are we?
We are the Oxford Centre for Emotions and Affective Neuroscience (OCEAN lab) led by Prof. Elaine Fox. We are situated at the Department of Experimental Psychology at the University of Oxford. Find us as http://www.psy.ox.ac.uk/research/ocean
What do we do?
We explore the link between psychological flexibility and wellbeing in a healthy adult population. We want to understand how cognitive and affective flexibility is linked to our mental wellbeing.
What do you have to do?
During a first session you will be asked to fill in some questionnaires and perform a computer based task, and engage in a brief interview about your mental wellbeing (the session will last around 40 minutes in total). After that we ask you to fill out online surveys once a week for 4 weeks (which will take around 5 minutes to complete). We will ask you to fill out online surveys again after 2 months, 6 months and 1 year (which will take around 20 minutes to complete) and engage in a brief telephone interview about your mental wellbeing after 2 months, 6 months and 1 year (which will take around 10 minutes).
You will be reimbursed for your time.
You can take time to think about it and ask questions before you decide whether or not to take part in our study! Your enquiry will be kept confidential and you will not be obliged to take part. Please do not hesitate to contact for more information
email@example.com (Holly Banfield - Trainee Clinical Psychologist)
Healthy male volunteers wanted for study to limit the impact of steroids
Targeting Iatrogenic Cushing's Syndrome with 11β-hydroxysteroid dehydrogenase type 1 Inhibition (TICSI)
2-3 percent of the population of the UK are prescribed steroid treatment to treat a wide variety of conditions. Whilst steroid treatment is very effective, it is associated with a significant number of side effects that can include weight gain, the development of diabetes, high blood pressure, fat in the liver and thinning of the muscles. Currently there are no treatments available to limit the side effects of steroid medication.
In previous studies, we have shown that an enzyme called 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates additional steroid in liver, fat and muscle and this has a detrimental impact upon how these tissues function. We believe that inhibiting 11β-HSD1 will be a new way to limit the side effects of prescribed steroids without compromising their anti-inflammatory actions.
AZD4017 is an inhibitor of 11β-HSD1 that has been used in many clinical studies.
We will use this drug in healthy male volunteers, in the first study of its kind, funded by the Medical Research Council, to see if we can limit the side effects of steroid treatment. The steroid medication that we will use in this study is called prednisolone and the effects of AZD4017 will be compared against a dummy pill (placebo). If the results of this study are positive, then it has the potential to change the way in which steroid medication is prescribed and to reduce the side effects of a commonly prescribed class of drug.
Nantia Othonos, Oxford Centre for Diabetes, Endocrinology and Metabolism
Tel: 01865 857359
Low in mood? Participants needed for emotional decision making drug study
We are looking for volunteers aged 18 - 65 who are currently feeling depressed to participate in a study investigating the effects of a new medication on emotional decision making.
If you are NOT taking antidepressant medication, you may be eligible for the RESTAND study.
- Duration: Four appointments (one screening visit, one first dose appointment, and two research visits) - about 13 hours in total
- Who can participate? Participants who are feeling depressed/low and not taking antidepressant medication or undergoing psychological therapy, aged 18 to 65
- What does the study involve? The study mainly involves taking medication for 7 days, computer-based psychological tasks, questionnaires and one brain imaging scan
REC Reference: 18/SC/0076
If you ARE taking antidepressant medication, you may be eligible for the RESTART study.
- Duration: Three appointments (one screening visit, one first dose appointment, and one research visit) about 11 hours in total
- Who can participate? Participants who are currently taking an antidepressant but are still feeling depressed/low despite this, aged 18 to 65
- What does the study involve? The study mainly involves taking medication for 7 days, computer-based psychological tasks and questionnaires
REC Reference: 18/SC/0074
For more information in confidence, with no obligation to participate, please contact our research team at either firstname.lastname@example.org or email@example.com. You will be reimbursed for your time!
The effect of seven day prucalopride administration on emotional processing in healthy volunteers
Healthy volunteers are needed for a study investigating the effects of seven-day administration of the drug prucalopride on the processing of emotions.
If you are healthy, aged 18-40 years, right-handed and have no history of a psychological disorder please contact us for more information. You will be asked questions about your medical history to check your suitability for an MRI scan.
The study is run at the Department of Psychiatry, Warneford Hospital, University of Oxford, over 3 sessions. The study involves a screening visit, and taking the drug or placebo for 7 days. The second visit includes a brain scan using functional Magnetic Resonance Imaging (fMRI). MRI is a type of brain scan that allows us to see how the brain is organised, processes information, and performs skills like speech or memory. This scan is safe and does not involve any needles or injections. The third visit includes computer-based psychological tasks.
Time and reasonable travel expenses will be reimbursed.
Central University Research Ethics Committee number: R57219/RE001
Have you had fertility treatment in the UK? Were you asked about the use of your data?
When patients start fertility treatment in England they have to fill in a lot of forms, and among these is an HFEA form to consent to disclose identifiable information. This is the form where people decide whether to allow their personal information to be used in research. We are trying to find out more about how people make this decision, and more about their experiences. We are looking for volunteers who would be willing to be interviewed.
If you might be able to help, or would like more information, please contact Dr Claire Carson at the National Perinatal Epidemiology Unit: firstname.lastname@example.org or (01865)289755
For more information, please see our study web page: https://www.npeu.ox.ac.uk/taking-part-study
Oxford Vaccine Group
The Oxford Vaccine Group, part of the Department of Paediatrics, is an independent multi-disciplinary clinical trials and epidemiology group based at the Centre for Clinical Vaccinology and Tropical Medicine. OVG works towards the goal of developing new and improved vaccines for the prevention of infection in adults and children, enhancing the understanding of immunity and studying the epidemiology of infectious diseases.
Oxford Education Deanery
We warmly welcome interest from teachers in local state-maintained schools that are members of the Oxford Education Deanery that want to engage with/in research and/or undertake continuing professional development. Opportunities available to eligible teachers include the NQT induction programme, Action Research Fellowships and the Enhanced Masters in Learning and Teaching. We are also keen to work collaboratively with local Deanery schools to develop research projects that meet school needs and disseminate findings effectively. If your school is not a Deanery member and you are interested in joining, please contact email@example.com.